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BACKGROUND: Many people display omission bias in medical deci-
sion making, accepting the risk of passive nonintervention rather than
actively choosing interventions (such as vaccinations) that result in
lower levels of risk.
OBJECTIVE: Testing whether people’s preferences for active interven-
tions would increase when deciding for others versus for themselves.
RESEARCH DESIGN: Survey participants imagined themselves in 1 of
4 roles: patient, physician treating a single patient, medical director
creating treatment guidelines, or parent deciding for a child. All read 2
short scenarios about vaccinations for a deadly flu and treatments for a
slow-growing cancer.
PARTICIPANTS: Two thousand three hundred and ninety-nine people
drawn from a demographically stratified internet sample.
MEASURES: Chosen or recommended treatments. We also measured
participants’ emotional response to our task.
RESULTS: Preferences for risk-reducing active treatments were signif-
icantly stronger for participants imagining themselves as medical pro-
fessionals than for those imagining themselves as patients
(vaccination: 73% [physician] & 63% [medical director] vs 48% [pa-
tient], Pso.001; chemotherapy: 68% & 68% vs 60%, Pso.012). Similar
results were observed for the parental role (vaccination: 57% vs 48%,
P=.003; chemotherapy: 72% vs 60%, Po.001). Reported emotional re-
actions were stronger in the responsible medical professional and pa-
rental roles yet were also independently associated with treatment
choice, with higher scores associated with reduced omission tenden-
cies (OR=1.15 for both regressions, Pso.01).
CONCLUSIONS: Treatment preferences may be substantially influ-
enced by a decision-making role. As certain roles appear to reinforce
‘‘big picture’’ thinking about difficult risk tradeoffs, physicians and pa-
tients should consider re-framing treatment decisions to gain new, and
hopefully beneficial, perspectives.
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C onsider the medical decision problem in Box 1. A deadlyflu threatens your area, killing 10% of the population,
and you must decide whether to get vaccinated. Although the
vaccine protects you from the flu epidemic, it also causes a
significant (5%) mortality risk of its own. Taking the vaccine
is the survival-maximizing choice. Doing so, however, may
increase your sense of responsibility for any harm that may
befall you.
Researchers have labeled this type of situation as an
omission bias problem and have consistently shown that many
people are willing to face higher risks of death to avoid having
‘‘caused’’ harm.1,2 In mail surveys of parents, those who dem-
onstrated omission tendencies in hypothetical scenarios were
less likely to report having their child vaccinated for pertussis
and more likely to believe that vaccinating their child was more
dangerous than not vaccinating, despite having received in-
formation to the contrary.3,4 Such omission tendencies prima-
rily result from people drawing a sharp distinction between
direct and indirect causation: People think about harms
caused by direct actions much more than harms caused only
indirectly.5
Susceptibility to omission ‘‘biases,’’ however, may differ by
what role people play in the decision-making process. Social
roles and authority relationships affect how much people dif-
ferentiate between harmful acts and harmful omissions.6 Spe-
cifically, if the actor holds a position with a high degree of
responsibility, people’s evaluations of a situation depend more
on the outcome of the decision than on who caused any harms.
Why would role and authority matter? One possibility is
that, when acting in roles with authority or social responsibil-
ity, people experience different emotional responses than
when deciding for themselves. In particular, role may influ-
ence visceral reactions such as anxiety or worry that are linked
to people’s intuitive understandings of risk and underlie cer-
tain self-other differences in decision making.7 While causing
harm is emotionally disturbing in every case, people might re-
act differently to the prospect of hurting themselves versus
causing harm to others as part of their duties or responsibil-
ities. Alternately, responsibility may make people analyze
decisions differently, focusing on certain components of the
decision more than others.8,9
Role and perspective could have a significant impact on
medical treatment decisions that compare active treatment
approaches with more passive approaches. Such decisions
commonly occur with life-threatening illnesses, because in-
tensive, life-saving interventions often have their own inherent
dangers. Despite the recent trend toward shared decision
making, some patients still cede decision authority to their
physicians and health care providers.10 But, do medical pro-
fessionals make the choices patients would want them to?
Ethically, the role of the physician is to help patients make
the ‘‘best’’ decision,11 but patients may use different decision-
making processes than physicians. Physicians’ professional
role and social distance might focus them more on the poten-
tial outcomes, whereas patients might focus more on how the
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outcomes are achieved (i.e., the story of their illness).12 Adopt-
ing a policy-making perspective could reinforce this difference.
For example, hospital medical directors might have an even
greater tendency toward objectivity than physicians, because
their decisions affect more people and because they must act
in the best interests of the majority even if doing so might bring
harm to a single person.13,14
Another important perspective is the parental role. Par-
ents’ immunization decisions are strongly influenced by omis-
sion bias factors, such as anticipated responsibility and
potential regret.15,16 While parents certainly have a sense of
responsibility about their children, there is also a close emo-
tional connection involved. Both factors could influence treat-
ment decision making.
In this study, we examined the potential impact of pro-
fessional and parental roles on omission tendencies in medical
treatment decisions. To identify how perspective and role may
affect decisions independent of the knowledge and experience
associated with becoming a medical professional, we used a
randomized experimental design to compare differently word-
ed versions of 2 medical decision scenarios. To further eluci-
date why different roles might lead to different treatment
decisions, we also assessed the degree to which taking on
these roles evoked emotional responses and whether those re-
sponses affected treatment choices.
METHODS
Overview of Study Design
As part of a larger internet-administered survey on medical
decision making, participants read descriptions of 2 medical
decisions: (1) vaccination for a deadly flu virus and (2) treat-
ment of a slow-growing cancer. We randomized participants to
consider these decisions while imagining themselves in 1 of 4
possible roles and then assessed their treatment preferences.
This design received Institutional Review Board exempt status
approval.
Participants
Study participants were drawn from a panel of internet users,
administered by Survey Sampling International (SSI), who all
voluntarily agreed to receive invitations to fill out question-
naires. To ensure demographic diversity (but not representa-
tiveness), email invitations were sent to a stratified random
sample of panel members weighted to offset expected differ-
ences in response rates (especially for African Americans and
Hispanic Americans), with the goal of approximating the U.S.
census on gender, education level, and income in the final
subject pool. We also drew 3 distinct age samples to enable
greater power for age-based analyses: one-third aged 21 to 40,
one-third aged 41 to 64, and one-third aged 65 and older.
Upon completion, participants were entered into a drawing
administered by SSI for cash prizes totaling $10,000.
Intervention
The main experimental manipulation involved asking re-
spondents to imagine themselves in 1 of 4 decision-making
roles. Some participants were told they were at risk and were
deciding their own course of treatment (‘‘self’’ role). A second
group imagined being physicians recommending a treatment
approach to a single patient of unspecified age and gender
(‘‘physician’’ role). A third group imagined acting as a hospital
medical director setting treatment guidelines for all patients
(‘‘medical director’’ role). The final group imagined being par-
ents of an at-risk minor child and making treatment decisions
for their son or daughter (‘‘parent’’ role). Participants were ran-
domly assigned among role conditions.
Regardless of role, respondents read both the deadly flu
vaccination scenario described above (Box 1) and a similarly
structured slow-growing cancer scenario (Appendix A, online)
in random order. Each scenario included an active treatment
(taking the vaccine or undergoing chemotherapy) and a pas-
sive treatment approach (no vaccine or watchful waiting). In
both cases, choosing active treatment reduced overall mortal-
ity by 5% versus the passive alternative. However, the mortal-
ity risk associated with active treatment was caused by the
vaccine or chemotherapy, whereas the larger mortality risk
associated with the other treatment choice occurred by
chance.
Between scenarios, respondents also completed a brief
measure, adapted from the PANAS,17 of the emotions evoked
by their task. Participants were shown 10 emotion words (anx-
ious, distressed, guilty, interested, conflicted, determined, un-
comfortable, concerned, worried, and responsible) and rated
how much reading the prior scenario made them feel each
emotion on a 1 to 5 scale (1=‘‘very slightly or not at all,’’
5=‘‘extremely’’). While we considered whether each
scenario evoked certain emotions more than others, our pri-
mary measure was the average emotional rating, which we
took to represent each respondent’s overall level of emotional
activation.
Outcome Measures
Our primary outcome measure was the treatment either
chosen or recommended by each respondent for the 2 scenar-
ios.
Box 1: Flu Scenario.
(Page 1)
Imagine that there will be a deadly flu going around your area next
winter. Your doctor says that you have a 10% chance (10 out of 100)
of dying from this flu.
Take a moment to vividly imagine what it would be like to be in this
situation.
(Page 2)
A new flu vaccine has been developed and tested. If taken, the
vaccine prevents you from catching the deadly flu. However, there is
1 serious risk involved with taking this vaccine. The vaccine is made
from a somewhat weaker type of flu virus, and there is a 5% (5 out of
100) risk of the vaccine causing you to die from the weaker type of
flu.
Imagine that this vaccine is completely covered by health insurance.
(Page 3)
Remember, you are imagining that you could get a type of deadly
flu. Please give your best answer to the following questions.
If you had to decide now, which would you choose?
 I would not take the vaccine and accept the 10% chance of
dying from this flu.
 I would take the vaccine and accept the 5% chance of dying
from the weaker flu in the vaccine.
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Hypotheses
We predicted that imagining oneself as a health care profes-
sional (i.e., physician or medical director) would evoke a sense
of duty to act in the ‘‘best interests’’ of patients and increase
attention to harms of omission, leading to greater selection of
active treatment versus participants in the self-role.
Past research suggests that people feel stronger emotions
about risks for oneself versus risks for others.7 Omission con-
texts trade off 2 risks, however: higher (passive) mortality risk
versus the risk of causing harm, both of which could evoke
emotional reactions. Our a priori belief was that the latter risk
would be less emotionally salient in health professional roles
versus the self condition, reducing overall emotional activation
and further reducing omission tendencies. We similarly antic-
ipated that participants reporting weaker emotional reactions
to our task would choose active treatment options more often.
As older adults pay more attention to affect and are more in-
fluenced by affective cues (e.g., emotional appeals) than
younger adults,18–21 the same logic suggests that younger sub-
jects would be more likely to choose active treatment than our
oldest participants (age 65 and older).
The parental role is more complex. While parental respon-
sibility should reinforce the need to maximize the chance of the
child surviving, the prospect of causing harm to one’s own
child might evoke particularly strong emotions, potentially off-
setting this effect. As a result, we had no a priori hypotheses
regarding behavior in the parent role condition. We did expect
greater emotional reactions from ‘‘parent’’ respondents com-
pared with the medical professional roles.
Statistical Analysis
We utilized w2 tests of proportions to test whether treatment
selections differed across role conditions and whether any re-
spondent demographic characteristics were associated with
treatment choice. We then used logistic regression to perform
multivariate analyses including role condition, demographic
variables, and reported emotion as potential explanatory
variables. All analyses were performed using STATA 8.
RESULTS
A total of 30,375 people received email invitations, and 2,917 (a
9.6% response rate) clicked the embedded link to see the survey
cover page. While some dropout occurred as people read fur-
ther, 2,399 participants (82.2%) provided useable data.
Sample mean age was 51 (range 21 to 89), 47% were male, and,
of the 2,124 who reported racial and ethnic background infor-
mation, 82% described themselves as Caucasian, 13% Hispanic
(any race), 10% African American, 2% Asian American, and 5%
multi-ethnic or other race. We observed a wide range of educa-
tional achievement, with 37% having completed a Bachelor’s or
higher degree but also 17% with only a high school education or
less. Compared with nonrespondents (using information from
SSI), participants were slightly older (mean age 51 vs 46) and
more educated (37% with Bachelor’s or higher degree vs 32%),
due to oversampling of younger adults needed to offset lower
response rates. Most importantly for testing our primary hy-
pothesis of role effects, there were no significant variations in
sample characteristics across the role conditions.
Role and Decision Making
Table 1 reports the percentage of survey participants who
chose the active treatment option by both decision-making
role and scenario type. In a clear demonstration of preferences
for inaction, a significant minority of participants declined the
survival-maximizing active treatment in all conditions, includ-
ing the 2 medical professional roles. However, the first 3 col-
umns show that, as predicted, the percentage of people
choosing active treatments increased significantly for subjects
imagining themselves in a professional role, compared with the
self role. The effect size was noticeably larger with the flu vac-
cine scenario than for the slow-growing cancer scenario. In the
flu scenario, ‘‘medical directors’’ were more likely to support
vaccination than even ‘‘physicians’’ (w2(1)=13.29, Po.001). No
such difference was observed in the cancer scenario.
The fourth column of Table 1 reports the results from the
parental role conditions. Here we observed a significant differ-
ence between the 2 scenarios. In the slow-growing cancer sce-
nario, people who imagined making a treatment decision for
their own child were more likely than all others to choose active
chemotherapy over watchful waiting. By contrast, in the flu
scenario, ‘‘parent’’ respondents were more likely to choose ac-
tive treatment (i.e., the vaccine) than respondents in the self-
role but less likely to do so than respondents in the medical
professional roles.
Within each role condition, treatment choices were similar
for the 2 youngest age cohorts (ages 21 to 40 and 41 to 64) in
both scenarios. However, respondents 65 years of age and old-
er were significantly less likely to undergo chemotherapy in the
slow-growing cancer scenario (M=58.9% vs 70.6%,
w2(1)=28.49, Po.001, consistent with our age hypothesis)
Table 1. Effect of Imagined Decision-Making Role on Willingness to Choose Active Treatment
Decision-Making Role
Self (n=629) Physician (n=554) Medical Director (n=550) Parent (n=586)
Deciding for Oneself 1 Patient All Patients Own Child
Flu scenario
% taking the vaccine 48 63 73 57
w2 test (1 df) vs self role — Po.001 Po.001 P=.003
Slow growing cancer scenario
% choosing chemotherapy 60 68 68 72
w2 test (1 df) vs self role — P=.008 P=.012 Po.001
In the flu scenario, all pairwise comparisons between the physician, medical director, and parent roles are also significant at Po.05 or better.
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but significantly more likely to take the vaccine in the deadly
flu scenario (M=66.4% vs 56.3%, w2(1)=19.39, Po.001, con-
trary to expectations but consistent with the strong provacci-
nation messages targeted at older adults). This pattern of
behavior was not role specific; similar significant age effects
were observed in all 4 role conditions, albeit at different base-
line likelihoods of choosing active treatment.
Affect and Decision Making
Our aggregate measure of emotional activation was signifi-
cantly related to participants’ imagined role, but not in accord
with our hypotheses. Scores were highest for respondents in
the parent role (M=2.93), next highest for the physician and
medical director roles (M=2.55 and 2.56, respectively), and
lowest for the self role (M=2.31). All pairwise comparisons
(except physician vs medical director) were highly significant
at Po.001. Female participants reported higher average scores
than male subjects (M=2.69 vs 2.46, t=5.75, Po.001), but
there was no significant interaction with respondent age. Our
decision to rely on an aggregate measure was supported by the
very similar response patterns for each of the 10 emotion
words. The findings are qualitatively similar even if only a sub-
set of the emotion responses are used.
We used a multivariate logistic regression framework to
test whether emotional activation would predict treatment
choice independent of its association with role. The results,
shown in Table 2, confirmed the main effects of role and age
discussed above and identified a gender effect in the flu sce-
nario. The emotion variable did have a small but significant
independent effect, with greater reported emotion levels re-
sulting in greater selection of active treatment in both scenar-
ios. Role remained a significant predictor even when emotion
was added to the regressions, suggesting that role acts on the
decision-making process in broader ways than just increasing
emotional activation.
DISCUSSION
Our results demonstrate that medical treatment decisions can
vary, often significantly, simply by changing the decision mak-
er’s perspective. Compared with respondents imagining them-
selves as patients, participants imagining themselves as
medical professionals making treatment recommendations to
patients (either individually or collectively) were significantly
more likely to choose the survival-maximizing actions of un-
dergoing chemotherapy and flu vaccination. This shift oc-
curred even though our research participants had neither
the formal training nor the professional experience of true
physicians. Their propensity to choose active treatment chan-
ged simply as a result of thinking about the problem from an
alternate perspective.
Our findings are consistent with previous research, which
suggests that, while people making decisions for themselves
consider many different dimensions, people giving advice to
others focus on a single dimension.8,22 After all, advice givers
may be asked to justify their decisions to others9 or feel a need
to justify them to themselves,23 and maximizing survival
chances is easy to defend. Our results also support previous
findings that people accept medical interventions more often
when choosing on behalf of another than when choosing for
themselves.24
Our aggregate measure of respondents’ emotions was sig-
nificantly related to treatment choices, although not as expect-
ed. Greater emotional activation mediated the role effect and
was independently correlated with choosing active treatment.
Clearly, we measured something important, although ‘‘emo-
tion’’ may not be the best label for this construct. Life and
death medical decisions are obviously emotional, yet the low
emotion scores of the ‘‘patient’’ respondents suggest that we
failed to pick up on these affective responses. A better label for
what we measured might be engagement. Imagining being re-
sponsible for a sick child or giving advice to patients may have
been more engaging than imagining (counterfactually) facing
an imminent risk of death. Greater engagement would have
induced people to focus on outcomes (i.e., survival) and thus
choose active treatment. The engagement concept is also con-
sistent with other unpublished research we have conducted
showing that imagining a high responsibility role reduces pro-
test responses in utility elicitation exercises.
Although this research did not involve actual treatment
decisions by patients or health care providers, it suggests that
physician advice is still an important role function.25 Physi-
cian recommendations have a powerful impact on patient de-
cisions,26 and the advent of patient involvement and shared
decision making in medicine has led some physicians to back
away from expressing their own preferences, believing instead
that their role should focus primarily on providing information
rather than guiding choices.27,28 Our results suggest that such
an approach may be problematic. Some patients may fear hav-
ing ‘‘caused’’ their own harm if an active treatment turns out
poorly yet at the same time recognize the advantages of sur-
vival-maximizing active treatments when choosing for another.
These patients may benefit from receiving treatment recom-
mendations from their physician (or family members). In
particular, providers may want to consider asking patients to
Table 2. Logistic Regression Analyses of the Selection of Active Treatment Options
Dependent Variable: Choice of the active treatment option Flu Scenario Slow Growing Cancer Scenario
Variable Odds Ratio z P-Value Odds Ratio z P-Value
Physician role (vs self) 1.71 4.25 o.001 1.39 2.56 .011
Medical director role (vs self) 2.92 8.10 o.001 1.38 2.49 .013
Parent role (vs self) 1.38 2.56 .010 1.65 3.71 o.001
Average emotion rating 1.15 2.70 .007 1.15 2.56 .010
Age 41 to 64 (vs 40) 0.87 1.22 .212 0.74 2.54 .011
Age 651 (vs 40) 1.43 3.09 .002 0.50 5.84 o.001
Male gender 1.24 2.30 .022 0.98 0.22 .823
Overall w2 (7 df) 105.51 62.09
JGIM 621Zikmund-Fisher et al., Choosing for Others Versus for Yourself
‘‘reframe’’ the decision they face and consider it as if they were
choosing for someone else. This shift in perspective may help
some patients better understand the tradeoffs they face.
Our research has several limitations. First, our survey
used an internet sample, which, although demographically di-
verse, may be nonrepresentative in unmeasured ways. Our
goal, however, was not to achieve a representative sampling
frame but instead to compare treatment choices between ex-
perimental groups. Our randomized design supports internal
validity by distributing sample peculiarities evenly across role
conditions, thus controlling for any response biases possibly
indicated by our low response rate. Second, our use of Internet
subjects and hypothetical scenarios may have reduced partic-
ipants’ motivation to take the task seriously, inflating tenden-
cies to choose passive treatment approaches. It seems likely
that people might be more survival focused when actually facing
life-threatening illnesses. Third, some subjects may have mis-
understood the risk information presented, increasing error.
Still, our experimental results should remain valid unless these
factors had a greater impact on decision making in the self role
condition than on decisions in the other 3 role conditions.
Medical decisions should be fact driven. Given a particu-
lar decision problem and a consistent set of facts, we expect
physicians and patients to see the situation similarly and thus
make similar decisions. Our results show that what seems
reasonable for yourself may seem less appropriate when giving
advice or acting on behalf of another, even though your per-
sonal values are the same in both cases. Although decision role
matters, we do not assert a single ‘‘correct’’ perspective. We do
suggest that medical professionals should reconsider the role
they play in facilitating patient decision making. What we
choose for ourselves is not always what we would choose for
another, and reflecting on this fact may help both patients and
physicians to improve their decisions.
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